An isogenic human stem cell model reveals NGLY1-dependent control of microglial development
En palabras de los autores
NGLY1 is a cytosolic N-glycanase involved in glycoprotein quality control and proteasome-mediated protein degradation and is critical for normal brain development and function. Although neuronal alterations caused by NGLY1 deficiency have been extensively characterized in animal and human cell models, how NGLY1 deficiency affects human glial cells, particularly microglia, the brain-resident innate immune cells, remains largely unknown. Using patient-derived NGLY1-deficient human induced pluripotent stem cell (hiPSC) lines and their corresponding CRISPR-mediated gene-corrected isogenic lines, we found that NGLY1-deficient primitive macrophage progenitors (PMPs) exhibited increased GlcNAc-Asn (GNA) accumulation and elevated expression of RUNX1, a key transcription factor regulating myeloid lineage development, accompanied by abnormal proliferation. Following further differentiation, NGLY1-deficient human microglia exhibited reduced morphological complexity and impaired phagocytic capacity. In addition, NGLY1-deficient microglia showed increased expression of pro-inflammatory cytokines, including IL-1{beta}, IL-6, and TNF, under both basal and stimulated conditions, indicative of a heightened inflammatory state. Mechanistically, our data showed that RUNX1 upregulation induced by NGLY1 deficiency partially mediated impaired PMP proliferation and subsequent microglial abnormalities, implicating RUNX1 dysregulation in NGLY1-associated microglial dysfunction and identifying RUNX1 as a potential therapeutic target. Together, using patient-derived and gene-corrected isogenic hiPSCs, our study establishes a human stem cell platform for modeling NGLY1 deficiency and reveals that impaired deglycosylation alters human microglial developmental trajectories and ultimately compromises microglial homeostasis and function. These microglial abnormalities may contribute to the neurological deficits observed in patients carrying loss-of-function variants in NGLY1.
Apareció: martes, 17 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.